Literature DB >> 11738828

A nonspecific nucleoside hydrolase from Leishmania donovani: implications for purine salvage by the parasite.

L Cui1, G R Rajasekariah, S K Martin.   

Abstract

In contrast to their mammalian hosts, protozoan parasites do not synthesize purines de novo, but depend on preformed nucleotides that they purportedly obtain by salvage pathways. Nucleoside hydrolases may play a crucial role in that salvage process. By screening Leishmania donovani libraries with polyclonal antibodies against promastigote soluble exo-antigens, we have identified a cDNA encoding a protein with significant homology to nonspecific and uridine-inosine-preferring nucleoside hydrolases. Sequence comparison demonstrated that all the residues involved in Ca(2+)-binding and substrate recognition in the active site are conserved among the characterized protozoan nucleoside hydrolases. Genomic analysis suggests that it is a single copy gene in L. donovani, and its homologues are present in members representing other Leishmania species complexes. Both Northern blot and immunoblot analyses indicate that it is constitutively expressed in L. donovani promastigotes. The recombinant enzyme overexpressed in and purified from bacteria showed significant activity with all naturally occurring purine and pyrimidine nucleosides, and efficient utilization of p-nitrophenyl-beta-D-ribofuranoside as a substrate. Altogether, the sequence comparison and substrate specificity data identify this L. donovani nucleoside hydrolase as a nonspecific nucleoside hydrolase. Further, the nucleoside hydrolase was localized to specific foci in L. donovani promastigotes by immunofluorescent assays. Although the conservation of the nucleoside hydrolases among protozoan parasites offers promise for the design of broad-spectrum anti-parasitic drugs, the existence of multiple and distinct nucleoside hydrolases in a single species demands special consideration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738828     DOI: 10.1016/s0378-1119(01)00768-5

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  21 in total

Review 1.  Purine salvage in Leishmania: complex or simple by design?

Authors:  Jan M Boitz; Buddy Ullman; Armando Jardim; Nicola S Carter
Journal:  Trends Parasitol       Date:  2012-06-20

2.  Structural and biochemical characterization of the nucleoside hydrolase from C. elegans reveals the role of two active site cysteine residues in catalysis.

Authors:  Ranjan Kumar Singh; Jan Steyaert; Wim Versées
Journal:  Protein Sci       Date:  2017-03-06       Impact factor: 6.725

Review 3.  Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

Authors:  Advait S Nagle; Shilpi Khare; Arun Babu Kumar; Frantisek Supek; Andriy Buchynskyy; Casey J N Mathison; Naveen Kumar Chennamaneni; Nagendar Pendem; Frederick S Buckner; Michael H Gelb; Valentina Molteni
Journal:  Chem Rev       Date:  2014-11-03       Impact factor: 60.622

4.  Genetic dissection of pyrimidine biosynthesis and salvage in Leishmania donovani.

Authors:  Zachary N Wilson; Caslin A Gilroy; Jan M Boitz; Buddy Ullman; Phillip A Yates
Journal:  J Biol Chem       Date:  2012-02-24       Impact factor: 5.157

5.  Amplification of adenine phosphoribosyltransferase suppresses the conditionally lethal growth and virulence phenotype of Leishmania donovani mutants lacking both hypoxanthine-guanine and xanthine phosphoribosyltransferases.

Authors:  Jan M Boitz; Buddy Ullman
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

6.  Construction of a Saccharomyces cerevisiae strain expressing the Leishmania major nucleoside hydrolase gene.

Authors:  Tamara K Miller; Champa Patel; Claude P Selitrennikoff
Journal:  Int J Antimicrob Agents       Date:  2006-12-01       Impact factor: 5.283

7.  Functional characterization of nucleoside transporter gene replacements in Leishmania donovani.

Authors:  Wei Liu; Jan M Boitz; Jon Galazka; Cassandra S Arendt; Nicola S Carter; Buddy Ullman
Journal:  Mol Biochem Parasitol       Date:  2006-09-27       Impact factor: 1.759

8.  Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis.

Authors:  Ingrid Aguilar-Be; Renata da Silva Zardo; Edilma Paraguai de Souza; Gulnara Patrícia Borja-Cabrera; Miguel Rosado-Vallado; Mirza Mut-Martin; Maria del Rosario García-Miss; Clarisa Beatriz Palatnik de Sousa; Eric Dumonteil
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

9.  Analysis of Bacillus anthracis nucleoside hydrolase via in silico docking with inhibitors and molecular dynamics simulation.

Authors:  Ana P Guimarães; Aline A Oliveira; Elaine F F da Cunha; Teodorico C Ramalho; Tanos C C França
Journal:  J Mol Model       Date:  2011-02-12       Impact factor: 1.810

10.  Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective response.

Authors:  Dirlei Nico; Carla Claser; Gulnara P Borja-Cabrera; Luiz R Travassos; Marcos Palatnik; Irene da Silva Soares; Mauricio Martins Rodrigues; Clarisa B Palatnik-de-Sousa
Journal:  PLoS Negl Trop Dis       Date:  2010-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.